Annual Operating Profit
-$201.61 M
-$1.42 M-0.71%
December 31, 2023
Summary
- As of February 7, 2025, ADPT annual operating income is -$201.61 million, with the most recent change of -$1.42 million (-0.71%) on December 31, 2023.
- During the last 3 years, ADPT annual operating profit has fallen by -$48.79 million (-31.93%).
- ADPT annual operating profit is now -362.03% below its all-time high of -$43.63 million, reached on December 31, 2017.
Performance
ADPT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$32.63 M
+$7.48 M+18.65%
September 30, 2024
Summary
- As of February 7, 2025, ADPT quarterly operating income is -$32.63 million, with the most recent change of +$7.48 million (+18.65%) on September 30, 2024.
- Over the past year, ADPT quarterly operating profit has increased by +$13.01 million (+28.50%).
- ADPT quarterly operating profit is now -256.21% below its all-time high of -$9.16 million, reached on September 30, 2018.
Performance
ADPT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$167.15 M
+$18.32 M+9.88%
September 30, 2024
Summary
- As of February 7, 2025, ADPT TTM operating income is -$167.15 million, with the most recent change of +$18.32 million (+9.88%) on September 30, 2024.
- Over the past year, ADPT TTM operating profit has increased by +$34.46 million (+17.09%).
- ADPT TTM operating profit is now -1172.23% below its all-time high of -$13.14 million, reached on March 31, 2018.
Performance
ADPT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ADPT Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | +28.5% | +17.1% |
| 3 y3 years | -31.9% | +37.9% | +28.4% |
| 5 y5 years | -305.2% | +37.9% | +28.4% |
ADPT Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +3.5% | at high | +48.3% | at high | +28.4% |
| 5 y | 5-year | -157.2% | +3.5% | -34.9% | +48.3% | -113.2% | +28.4% |
| alltime | all time | -362.0% | +3.5% | -256.2% | +48.3% | -1172.2% | +28.4% |
Adaptive Biotechnologies Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.63 M(-18.6%) | -$167.15 M(-9.9%) |
| Jun 2024 | - | -$40.11 M(-17.7%) | -$185.47 M(-4.0%) |
| Mar 2024 | - | -$48.76 M(+6.8%) | -$193.18 M(-4.2%) |
| Dec 2023 | -$201.61 M(+0.7%) | -$45.64 M(-10.4%) | -$201.61 M(+3.3%) |
| Sep 2023 | - | -$50.96 M(+6.6%) | -$195.15 M(+2.9%) |
| Jun 2023 | - | -$47.82 M(-16.4%) | -$189.63 M(-2.4%) |
| Mar 2023 | - | -$57.19 M(+46.0%) | -$194.31 M(-2.9%) |
| Dec 2022 | -$200.19 M(-4.2%) | -$39.19 M(-13.7%) | -$200.19 M(-10.1%) |
| Sep 2022 | - | -$45.43 M(-13.5%) | -$222.60 M(-4.7%) |
| Jun 2022 | - | -$52.50 M(-16.8%) | -$233.49 M(+1.2%) |
| Mar 2022 | - | -$63.07 M(+2.4%) | -$230.75 M(+10.4%) |
| Dec 2021 | -$208.97 M | -$61.60 M(+9.4%) | -$208.97 M(+9.1%) |
| Sep 2021 | - | -$56.33 M(+13.2%) | -$191.61 M(+11.2%) |
| Jun 2021 | - | -$49.77 M(+20.6%) | -$172.33 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$41.28 M(-6.7%) | -$159.48 M(+4.4%) |
| Dec 2020 | -$152.82 M(+94.9%) | -$44.24 M(+19.4%) | -$152.82 M(+15.1%) |
| Sep 2020 | - | -$37.05 M(+0.4%) | -$132.77 M(+16.7%) |
| Jun 2020 | - | -$36.91 M(+6.6%) | -$113.77 M(+22.4%) |
| Mar 2020 | - | -$34.62 M(+43.1%) | -$92.97 M(+18.6%) |
| Dec 2019 | -$78.39 M(+57.6%) | -$24.19 M(+34.0%) | -$78.39 M(+14.7%) |
| Sep 2019 | - | -$18.05 M(+12.1%) | -$68.35 M(+15.0%) |
| Jun 2019 | - | -$16.11 M(-19.7%) | -$59.45 M(+4.9%) |
| Mar 2019 | - | -$20.05 M(+41.7%) | -$56.66 M(+13.9%) |
| Dec 2018 | -$49.76 M(+14.0%) | -$14.14 M(+54.4%) | -$49.76 M(+39.7%) |
| Sep 2018 | - | -$9.16 M(-31.2%) | -$35.61 M(+34.6%) |
| Jun 2018 | - | -$13.31 M(+1.3%) | -$26.45 M(+101.3%) |
| Mar 2018 | - | -$13.14 M | -$13.14 M |
| Dec 2017 | -$43.63 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual operating income?
- What is the all time high annual operating profit for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual operating profit year-on-year change?
- What is Adaptive Biotechnologies quarterly operating income?
- What is the all time high quarterly operating profit for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly operating profit year-on-year change?
- What is Adaptive Biotechnologies TTM operating income?
- What is the all time high TTM operating profit for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM operating profit year-on-year change?
What is Adaptive Biotechnologies annual operating income?
The current annual operating profit of ADPT is -$201.61 M
What is the all time high annual operating profit for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual operating income is -$43.63 M
What is Adaptive Biotechnologies annual operating profit year-on-year change?
Over the past year, ADPT annual operating income has changed by -$1.42 M (-0.71%)
What is Adaptive Biotechnologies quarterly operating income?
The current quarterly operating profit of ADPT is -$32.63 M
What is the all time high quarterly operating profit for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly operating income is -$9.16 M
What is Adaptive Biotechnologies quarterly operating profit year-on-year change?
Over the past year, ADPT quarterly operating income has changed by +$13.01 M (+28.50%)
What is Adaptive Biotechnologies TTM operating income?
The current TTM operating profit of ADPT is -$167.15 M
What is the all time high TTM operating profit for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM operating income is -$13.14 M
What is Adaptive Biotechnologies TTM operating profit year-on-year change?
Over the past year, ADPT TTM operating income has changed by +$34.46 M (+17.09%)